title: Osteoprotegerin, thiazolidinediones treatment, and silent myocardial ischemia in type 2 diabetic patients.
authors: Service des Maladies Métaboliques, CHU Montpellier, Hôpital Lapeyronie, Montpellier, France.
authors: Ariane
authors: A
authors: Sultan
authors: Antoine
authors: A
authors: Avignon
authors: Florence
authors: F
authors: Galtier
authors: Christophe
authors: C
authors: Piot
authors: Denis
authors: D
authors: Mariano-Goulart
authors: Anne Marie
authors: AM
authors: Dupuy
authors: Jean Paul
authors: JP
authors: Cristol
mesh_terms: D000367:Age Factors; D000368:Aged; D001794:Blood Pressure; D015992:Body Mass Index; D016022:Case-Control Studies; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003404:Creatinine / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000150:complications*; D053244:Osteoprotegerin / Q000097:blood*; D012737:Sex Factors; D045162:Thiazolidinediones / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D003404:Creatinine; D006442:Glycated Hemoglobin; D053244:Osteoprotegerin; D045162:Thiazolidinediones; D014280:Triglycerides; C517652:hemoglobin A1c protein, human